A detailed history of Fortis Group Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 60 shares of ZTS stock, worth $10,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 60 -0.0%
Holding current value
$10,540
Previous $10.4 Million 12.7%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$165.67 - $199.94 $9,940 - $11,996
-60 Reduced 50.0%
60 $10.2 Million
Q4 2023

Mar 04, 2024

BUY
$151.44 - $200.09 $9,086 - $12,005
60 Added 100.0%
120 $23.7 Million
Q3 2023

Dec 01, 2023

BUY
$167.14 - $192.77 $10,028 - $11,566
60 New
60 $10.4 Million
Q1 2023

May 26, 2023

SELL
$145.48 - $175.02 $804,940 - $968,385
-5,533 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$137.1 - $165.37 $758,574 - $914,992
5,533 New
5,533 $914,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.